A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro

Cellular Immunology

Volumn 282, Issue 2, 2013, Pages 136-145

  Chalmers, Samantha A ^a   Eidelman, Alec S ^a   Ewer, Jason C ^a   Ricca, Jacob M ^a   Serrano, Antonio ^a   Tucker, Kyle C ^a   Vail, Caroline M ^a   Kurt, Robert A ^a  

^a LAFAYETTE COLLEGE   (United States)

Author keywords

4T1; Breast cancer; HMGB1; HSP60; Myd88

Indexed keywords

CHAPERONIN 60; DAMAGE ASSOCIATED MOLECULAR PATTERN PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; SMALL INTERFERING RNA; STAUROSPORINE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

4T1; BREAST CANCER; HMGB1; HSP60; MYD88;

ANIMALS; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHAPERONIN 60; CHEMOKINE CCL2; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 9; MICE; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDES; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MURINAE;

EID: 84879148474     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.04.014     Document Type: Article

References (30)

1. Palha De Sousa C., Blum C.M., Sgroe E.P., Crespo A.M., Kurt R.A. Murine mammary carcinoma cells and CD11c+ dendritic cells elicit distinct responses to lipopolysaccharide and exhibit differential expression of genes required for TLR4 signaling. Cell. Immunol. 2010, 266:67-75.
2. Egunsola A.T., Zawislak C.L., Akuffo A.A., Chalmers S.A., Ewer J.C., Vail C.M., Lombardo J.C., Perez D.N., Kurt R.A. Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. Cell. Immunol. 2012, 272:220-229.
3. Srikrishna G., Freeze H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11:615-628.
4. Mayer M.P. Gymnastics of molecular chaperones. Molecular Cell 2010, 39:321-331.
5. More S.H., Breloer M., von Bonin A. Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses: HSP60-mediated activation of cytotoxic T cells. Int. Immunol. 2001, 13:1121-1127.
6. Osterloh A., Meier-Stiegen F., Veit A., Fleischer B., von Bonin A., Breloer M. Lipopolysaccharide-free heat shock protein 60 activates T cells. J. Biol. Chem. 2004, 279:47906-47911.
7. Osterloh A., Kalinke U., Weiss S., Fleischer B., Breloer M. Synergistic and differential modulation of immune responses by HSP60 and lipopolysaccharide. J. Biol. Chem. 2007, 282:4669-4680.
8. Tsai Y., Yang M., Huang C., Chang S., Chen P., Liu C., Teng S, Wu K. Interaction between HSP60 and β-catenin promotes metastasis. Carcinogenesis 2009, 30:1049-1057.
9. Barazi H.O., Zhou L., Templeton N.S., Krutzsch H.C, Roberts D.D. Identification of heat shock protein 60 as a molecular mediator of α3β1 integrin activation. Cancer Res. 2002, 62:1541-1548.
10. Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta 2010, 1799:101-113.
11. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 2004, 173:307-313.
12. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., Arnold B., Bianchi M.E., Manfredi A.A., Rovere-Querini P. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 2005, 174:7506-7515.
13. Wild C.A., Bergmann C., Fritz G., Schuler P., Hoffmann T.K., Lotfi R., Westendorf A., Brandau S., Lang S. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int. Immunol. 2012, 24:485-494.
14. Liu Z., Falo L.D., You Z. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. J. Immunol. 2011, 187:118-125.
15. Song B., Song W.G., Li Z.J., Xu Z.F., Wang X.W., Wang C.X., Liu J. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem. Funct. 2012, 30:11-17.
16. Yan W., Chan Y., Liang X., Cardinal J.S., Huang H., Thome S.H., Monga S.P., Geller D.A., Lotze M.T., Tsung A. High mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 2012, 55:1863-1875.
17. Andrews J.L., Kim A.C., Hens J.R. The role and function of cadherins in the mammary gland. Breast Cancer Res. 2012, 14:203.
18. Li Y., Si R., Feng Y., Chen H.H., Zou L., Wang E., Zhang M., Warren H.S., Sosnovik D.E., Chao W. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and toll-like receptor 4. J. Biol. Chem. 2011, 286:30308-31319.
19. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J., Strassheim D., Sohn J., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E. High mobility group box 1 protein interacts with multiple toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:917-924.
20. Rechsteiner M., Kuehl L. Microinjection of nonhistone chromosomal protein HMG1 into bovine fibroblasts and HeLa cells. Cell 1979, 16:901-908.
21. Lanks K.W. Metabolite regulation of heat shock protein levels. Proc. Natl. Acad. Sci. 1983, 80:5325-5329.
22. Chun J.N., Choi B., Lee K.W., Lee D.J., Kang D.H., Lee J.Y., Song I.S., Kim H.I., Lee S., Kim H.S., Lee N.K., Lee S.Y., Lee K., Kim J., Kang S.W. Cytosolic Hsp60 is involved in the NF-kB-dependent survival of cancer cells via IKK regulation. PLoS One 2010, 5:1-15.
23. high dendritic cell differentiation. Cytokine 2011, 54:205-211.
24. Jiao Y., Wang H., Fan S. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol. Sin. 2007, 28:1957-1967.
25. Sims G.P., Rowe D.C., Rietdijk S.T., Herbst R., Coyle A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28:367-388.
26. Watanabe M.A., Oda J.M., Amarante M.K., Cesar Voltarelli J. Regulatory T cells and breast cancer: implications for immunopathogenesis. Cancer Metastasis Rev. 2010, 29:569-579.
27. Montero A.J., Diaz-Montero C.M., Kyriakopoulos C.E., Bronte V., Mandruzzato S. Myeloid-derived suppressor cells in cancer patients: a clinical perspective. J. Immunother. 2012, 35:107-115.
28. Rakoff-Nahoum S., Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through adaptor protein Myd88. Science 2007, 317:124-127.
29. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K.H., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in Myd88-dependent IL-6 production. Science 2007, 317:121-124.
30. Coste I., Le Corf K., Kfoury A., Hmitou I., Druillennec S., Hainaut P., Eychene A., Lebecque S., Renno T. Dual function of Myd88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J. Clin. Invest. 2010, 120:3663-3667.